Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vella

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Chemotherapy|January 1, 1972
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazinoacethydrazone, a new hydrosoluble nitrofurane derivative. I. In vivo antibacterial activityL Degen, M Salvaterra, S Vella
Medicina (Florence, Italy)|April 1, 1990
[Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes]L Sarmati, S Vella, G Rocchi
Schweizerische Medizinische Wochenschrift|August 5, 1997
[PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis]A Schibler, P Birrer, S Vella
British Journal of Haematology|March 22, 2003
Palmodigital purpura as the only skin abnormality in myeloma-associated systemic amyloidosisFrancesco S Vella, Barbara Simone, Salvatore Antonaci
The American Journal of Medicine|May 12, 2001
Vertebral amyloidoma in a patient with primary systemic amyloidosisF S Vella, B Simone, S Antonao
QJM : Monthly Journal of the Association of Physicians|December 16, 2010
What to add in with metformin in type 2 diabetes?J R Petrie, A Adler, S Vella
Current Opinion in Psychiatry|November 6, 2025
The incidence of dementia in populations around the globeAshleigh S Vella, Susanne Roehr, Perminder S Sachdev
Chemotherapy|January 1, 1973
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activityL Degen, M Salvaterra, S Vella, et al.
Medicina (Florence, Italy)|October 1, 1990
[Infectious diseases]S Vella, L Sarmati, G Milanese, et al.
AIDS Clinical Care|May 1, 1996
The use of protease inhibitors. A sampling of opinions. Interview by Deborah J CottonL Corey, M Hirsch, G Skowron, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Chemotherapy|January 1, 1972
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazinoacethydrazone, a new hydrosoluble nitrofurane derivative. I. In vivo antibacterial activityL Degen, M Salvaterra, S Vella
Medicina (Florence, Italy)|April 1, 1990
[Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes]L Sarmati, S Vella, G Rocchi
Schweizerische Medizinische Wochenschrift|August 5, 1997
[PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis]A Schibler, P Birrer, S Vella
British Journal of Haematology|March 22, 2003
Palmodigital purpura as the only skin abnormality in myeloma-associated systemic amyloidosisFrancesco S Vella, Barbara Simone, Salvatore Antonaci
The American Journal of Medicine|May 12, 2001
Vertebral amyloidoma in a patient with primary systemic amyloidosisF S Vella, B Simone, S Antonao
QJM : Monthly Journal of the Association of Physicians|December 16, 2010
What to add in with metformin in type 2 diabetes?J R Petrie, A Adler, S Vella
Current Opinion in Psychiatry|November 6, 2025
The incidence of dementia in populations around the globeAshleigh S Vella, Susanne Roehr, Perminder S Sachdev
Chemotherapy|January 1, 1973
Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activityL Degen, M Salvaterra, S Vella, et al.
Medicina (Florence, Italy)|October 1, 1990
[Infectious diseases]S Vella, L Sarmati, G Milanese, et al.
AIDS Clinical Care|May 1, 1996
The use of protease inhibitors. A sampling of opinions. Interview by Deborah J CottonL Corey, M Hirsch, G Skowron, et al.
Pageof 18